{"schema_version":"secwatch.filing_event.v1","accession":"0001370053-24-000029","form_type":"8-K","ticker":"ANAB","cik":"0001370053","company_name":"ANAPTYSBIO, INC","filed_at":"2024-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.117661+00:00","generated_at":"2026-06-01T04:48:19.473185+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"AnaptysBio shareholders elect three Class I directors and approve equity plan amendment at 2024 annual meeting","bullets":["Daniel Faga, Dennis Fenton, and Oleg Nodelman elected as Class I directors with 22.3M, 21.9M, and 18.8M votes for, respectively.","Ratification of KPMG as independent auditor for FY 2024 approved with 24.7M shares for, 30k against.","Non-binding advisory vote on executive compensation passed with 19.9M for, 2.95M against.","Amendment and restatement of 2017 Equity Incentive Plan approved with 16.8M for, 4.7M against, 1.3M abstentions."],"urls":{"canonical":"https://secwatch.observer/filing/0001370053-24-000029","json":"https://secwatch.observer/filing/0001370053-24-000029.json","markdown":"https://secwatch.observer/filing/0001370053-24-000029.md","text":"https://secwatch.observer/filing/0001370053-24-000029.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1370053/000137005324000029/0001370053-24-000029-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1370053/000137005324000029/anab-20240612.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:48:19.473185+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}